
|Articles|May 17, 2004
FDA: Pancreatic enzyme drugmakers must submit NDA
Certain pancreatic drugs could be withdrawn from market unless their manufacturers go through NDA process
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FAQ: The Medicare GLP-1 Bridge—What Independent Pharmacists Need to Know
2
Grocery Pharmacy Conglomerate to Pay $40 Million for Violating False Claims Act
3
HHS Claims ACIP Cannot Meet for Flu Season Due to Ongoing Legal Battle
4
US Controlled Substance Market Expected to Grow $21 Billion by 2035
5




































